106
Participants
Start Date
August 28, 2018
Primary Completion Date
June 9, 2023
Study Completion Date
November 6, 2023
Diagnostic MRI
Participants will be scanned using a standard clinical prostate MRI protocol.
Diagnostic Prostate Biopsy
Participants will undergo a prostate biopsy as their standard of care treatment. The provider performing biopsy will select areas to be biopsies as part of normal clinical judgment.
Risk Map DSS tool
The Risk Map DSS tool will select up to 2 additional areas to be biopsied based on analysis of MRI images. The clinical provider will make final decision on areas to be biopsied.
University of Chicago Medical Center, Chicago
University of Chicago
OTHER